In approximately 48.4% of primary AML cells and 50% of AML cell lines, the mRNA level of SOCS1 was lower (Fig. 1a, b) and its promoter methylation was higher (Fig. 1c, d) than that in bone marrow cells from healthy donors. This evidence concerns the gene SOCS1 and acute myeloid leukemia.